Epidemiology and Comorbidity of Vitiligo in Germany: A Claims Data Analysis
Acta Dermato-Venereologica · 2026
DOI: 10.2340/actadv.v106.44468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2026. Verfasst von Theresa Klinger und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. t.klin…. Hauptthemen laut MEDLINE: Vitiligo. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Vitiligo is a chronic skin disease resulting in destruction of melanocytes and loss of pigmentation. Little is known about epidemiology and comorbidity in Germany. This retrospective cohort analysis used nationwide statutory health insurance data (2016 to 2020). Disease rates were calculated using varying case definitions. Comorbidity was assessed against 3 control groups: persons without vitiligo, with atopic dermatitis, and with psoriasis (1:3 propensity score matching). In 2020, 4,631 persons were diagnosed with vitiligo in DAK-Gesundheit (DAK-G, mean age 56.93 years, ~148,437) and 5,820 persons in the German Analysis Database for Evaluation and Health Services Research (~144,855). Prevalence ranged from 0.12% (confidence interval [CI] 0.12–0.12) to 0.20% (CI 0.19–0.20), and incidence from 0.04% (CI 0.03–0.04) to 0.06% (CI 0.06–0.06). Rates increased with age. Women (mean age 58.60 years) were more frequently affected. Vitiligo was associated with alopecia areata (relative risk 7.14, CI 4.63–11.00) and systemic sclerosis (relative risk 3.20, CI 1.58–6.47). Several mental illnesses (depression: relative risk = 1.23, CI 1.15–1.32, anxiety: relative risk = 1.32, CI 1.19–1.47), were linked to skin diseases like vitiligo, atopic dermatitis, or psoriasis. Vitiligo affects a notable proportion of the population, with detected comorbidities supporting prior findings. To ensure reliable results, claims data should be validated through primary data linkage or sensitivity testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. t.klinger@uke.de.
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
- Incyte Biosciences Germany, Munich, Germany.
- Gesundheitsforen Leipzig GmbH, Leipzig, Germany.
- inav - Private Institute for Applied Health Services Research GmbH, Berlin, Germany.
- Department of Dermatology, University of Münster, Münster, Germany.
ORCID-Profile: Theresa Klinger, Matthias Augustin, Markus Böhm, Kristina Hagenström
Zitieren
APA
Klinger, T., Augustin, M., Baumeister, S., Riedel, J., Grellmann, C., Kamps, A., Böhm, M., & Hagenström, K. (2026). Epidemiology and Comorbidity of Vitiligo in Germany: A Claims Data Analysis. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v106.44468
Vancouver
Klinger T, Augustin M, Baumeister S, Riedel J, Grellmann C, Kamps A, et al. Epidemiology and Comorbidity of Vitiligo in Germany: A Claims Data Analysis. Acta Dermato-Venereologica. 2026. doi:10.2340/actadv.v106.44468
BibTeX
@article{Klinger2026,
author = {Klinger, Theresa and Augustin, Matthias and Baumeister, Susanne and Riedel, Jennifer and Grellmann, Claudia and Kamps, Anja and Böhm, Markus and Hagenström, Kristina},
title = {Epidemiology and Comorbidity of Vitiligo in Germany: A Claims Data Analysis},
journal = {Acta Dermato-Venereologica},
year = {2026},
doi = {10.2340/actadv.v106.44468}
}
EUVIMED